Squarepoint’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
OFM
LCM
DFO
Squarepoint's NUVB Position: Q2 2026 in Review
Squarepoint increased its Nuvation Bio (NUVB) stake by 31% in Q2 2026, buying an estimated $192K and bringing the position to 164,211 shares worth $933K. The position accounts for ﹤0.01% of the portfolio, ranked #2953.
Squarepoint first reported a position in NUVB in Q1 2021 and has held it in 15 quarters since. The position peaked at $1.12M in Q3 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- Squarepoint held 164,211 shares of Nuvation Bio worth $933K as of Q2 2026.
- Squarepoint bought 39,267 Nuvation Bio shares in Q2 2026, an estimated $192K.
- Nuvation Bio made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2953 holding.
- Squarepoint first reported a position in Nuvation Bio in Q1 2021 and has held it in 15 quarters since.
- Squarepoint's Nuvation Bio position peaked at $1.12M in Q3 2025.
- 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.